This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Borreliella burgdorferi Basic Membrane Protein A (bmpA), MBP
Product Overview
BioVenic's Recombinant Borreliella burgdorferi Basic Membrane Protein A (bmpA), MBP is a recombinant protein expressed from E.coli. Its predicted molecular weight is 37.0 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
In the veterinary field, Borreliella burgdorferi basic membrane Protein A (BmpA) is an important immunogenic protein, commonly used for serodiagnosis of Lyme disease. BmpA can induce inflammatory responses during infection, promoting the aggregation of inflammatory cells, and thus plays a key role in the development of Lyme arthritis. Additionally, research on BmpA helps to better understand the pathogenesis of Lyme disease, providing an important basis for its diagnosis and treatment.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.